ConceptioArchiveScholar Commons
Scholar Commonsmetadata only

Cost-Effectiveness of Donanemab and Lecanemab Over a Lifetime Horizon for Patients with Early Alzheimers Disease

Jiang, Xiangxiang et al.
Scholar Commons · Other
Open Source ↗
research
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 323896
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.